- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 249/08 - 1,2,4-TriazolesHydrogenated 1,2,4-triazoles
Patent holdings for IPC class C07D 249/08
Total number of patents in this class: 1204
10-year publication summary
|
106
|
85
|
66
|
59
|
69
|
64
|
49
|
62
|
50
|
47
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| BASF SE | 21098 |
67 |
| Karyopharm Therapeutics Inc. | 143 |
40 |
| Corteva Agriscience LLC | 2702 |
38 |
| Kureha Corporation | 1039 |
30 |
| Bayer Cropscience AG | 1983 |
18 |
| BASF Agro B.V. | 202 |
16 |
| Bristol-myers Squibb Company | 4826 |
15 |
| Ardea Biosciences, Inc. | 71 |
15 |
| Dow AgroSciences LLC | 1214 |
14 |
| Nippon Soda Co., Ltd. | 892 |
11 |
| Merck Sharp & Dohme LLC | 3732 |
11 |
| Novartis AG | 10612 |
10 |
| Boehringer Ingelheim International GmbH | 4636 |
10 |
| Janssen Pharmaceutica N.V. | 3358 |
10 |
| Amgen Inc. | 4256 |
10 |
| Theravance Biopharma R&D IP, LLC | 453 |
9 |
| Merck Sharp & Dohme Corp. | 2189 |
8 |
| Bayer Pharma AG | 1048 |
8 |
| Board of Regents, The University of Texas System | 5946 |
8 |
| Astellas Pharma Inc. | 1057 |
8 |
| Other owners | 848 |